What is DXCM's health score?

DEXCOM INC (DXCM) has a TradeApes health score of 59 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is DXCM's estimated fair value?

Based on our 5-year discounted cash flow model, DEXCOM INC's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is DXCM undervalued or overvalued?

Our model currently rates DXCM as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for DXCM... Refresh in a moment for the full analysis.

DEXCOM INC (DXCM)

Healthcare Overvalued low mixed

$72.59

Updated: 2026-06-05

TradeApes Score

Financial Strength

85 Strong

Operating Trend

55 Mixed

Relative Value

38 Weak

Capital Allocation

50 Mixed

Risk

70 Healthy

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Extreme P/E — above 45×, very high expectations embedded in price

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.